Compare INTT & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INTT | LFMD |
|---|---|---|
| Founded | 1981 | 1994 |
| Country | United States | United States |
| Employees | N/A | 384 |
| Industry | Semiconductors | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 234.0M | 236.7M |
| IPO Year | 1997 | N/A |
| Metric | INTT | LFMD |
|---|---|---|
| Price | $17.40 | $4.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $13.50 | $9.14 |
| AVG Volume (30 Days) | 358.3K | ★ 822.2K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $66,801,000.00 | N/A |
| Revenue This Year | $15.82 | $17.52 |
| Revenue Next Year | $9.10 | $18.73 |
| P/E Ratio | $279.83 | ★ N/A |
| Revenue Growth | ★ 66.06 | N/A |
| 52 Week Low | $6.63 | $2.60 |
| 52 Week High | $20.00 | $15.34 |
| Indicator | INTT | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 53.46 | 52.30 |
| Support Level | $14.89 | $3.39 |
| Resistance Level | $19.91 | $4.74 |
| Average True Range (ATR) | 1.34 | 0.34 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 61.38 | 50.24 |
inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.